A randomized, placebo-controlled study of donepezil in poststroke aphasia.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 17101908.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied 26 patients in a randomized, placebo-controlled, double-blind parallel trial to evaluate the efficacy and safety of donepezil in chronic poststroke aphasia. Donepezil (10 mg/day) improved aphasia severity at endpoint (week 16) relative to placebo (p = 0.037).
Medical subject headings
- Aphasia
- Indans
- Piperidines
- Stroke